Form 4: Medpace Exec Sells 2,000 Shares

Medpace Holdings, Inc. Executive Vice President of Operations, Susan E. Burwig, reported the sale of 2,000 shares of common stock for approximately $1.21 million.

Summary

• Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. (MEDP), sold 2,000 shares of common stock.
• The transaction occurred on October 27, 2025.
• The shares were sold at a weighted average price of $605.01 per share, with individual transactions ranging from $605.00 to $605.13, totaling approximately $1,210,020.
• Following this transaction, Ms. Burwig directly beneficially owns 65,500 shares of Medpace common stock.
• The sale was executed pursuant to a limit order placed by the Reporting Person during an open window period.

Sentiment

Score: 4

Explanation: The sale of shares by an executive, while potentially for personal financial planning, can be viewed with slight caution by investors as it reduces insider ownership and could imply a less optimistic outlook, even if not explicitly stated.

Negatives

• An executive selling shares, even if for personal financial planning, can be perceived by some investors as a potential signal of limited upside or a lack of strong conviction in the company's immediate future performance.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may perceive the executive's sale of shares as a slight negative signal regarding the company's short-term prospects or valuation.

Key Dates

Recommendation

While an executive sale of 2,000 shares is not a massive disposition, it warrants a 'hold' recommendation rather than a 'buy' due to the potential for negative market perception. Investors should monitor future insider activity and company performance for clearer signals, as this single transaction does not provide enough information for a strong directional call.

Keywords

Medpace, MEDP, Insider Sale, Executive Transaction, Form 4, Stock Disposition, Susan E. Burwig, Operations Executive